Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: Examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Critical Care Medicine

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00003246-200107001-00026PMID 11445739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response

  2001cited by this paper
• Gender differences in sepsis: genetically determined?

  2000cited by this paper
• The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis.

  2000cited by this paper
• Peritonitis in the baboon: a primate model which stimulates human sepsis.

  2000cited by this paper
• Complement activation after oxidative stress: role of the lectin complement pathway.

  2000cited by this paper
• Mesenteric lymph duct ligation provides long term protection against hemorrhagic shock-induced lung injury.

  2000cited by this paper
• Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli.

  2000cited by this paper
• The Soluble Endothelial Protein C Receptor Binds to Activated Neutrophils: Involvement of Proteinase-3 and CD11b/CD181

  2000cited by this paper
• The Endothelial Cell Protein C Receptor

  2000cited by this paper
• Hypoxia/Hypoxemia-Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis.

  1999cited by this paper
• Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1.

  1999cited by this paper
• Endothelial Protein C Receptor

  1999cited by this paper
• Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin.

  1999cited by this paper
• Upregulation of ICAM-1 on cardiomyocytes in jeopardized human myocardium during infarction.

  1999cited by this paper
• Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.

  1998cited by this paper
• Active Site Inhibited Factor VIIa (DEGR VIIa) Attenuates the Coagulant and Interleukin-6 and -8, but not Tumor Necrosis Factor, Responses of the Baboon to LD100 Escherichia coli

  1998cited by this paper
• Attenuation of Tissue Thrombosis and Hemorrhage by ala-TFPI Does not Account for Its Protection against E. coli

  1998cited by this paper
• Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli.

  1998influential reference
• Role of cytokines in sepsis.

  1997cited by this paper
• Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion.

  1997cited by this paper
• C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction.

  1997cited by this paper
• Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis

  1997cited by this paper
• Coagulation Factors VII and X Induce Ca2+ Oscillations in Madin-Darby Canine Kidney Cells Only When Proteolytically Active*

  1996cited by this paper
• A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon

  1996cited by this paper
• Up-regulation of lung vascular ICAM-1 in rats is complement dependent.

  1995cited by this paper
• Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons.

  1995cited by this paper
• Endogenous IL-10 protects mice from death during septic peritonitis.

  1995cited by this paper
• Book reviewMolecular biology of free radical scavenging systems: John G. Scandalios, (ed.), Cold Spring Harbor University Press, 1992, ISBN 0-87969-409-2, 284 pp

  1995cited by this paper
• Circulating interleukin-6 receptor in patients with sepsis syndrome.

  1995cited by this paper
• Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock.

  1995cited by this paper
• Binding of Human Factor VIIa to Tissue Factor Induces Cytosolic Ca2+ Signals in J82 Cells, Transfected COS-1 Cells, Madin-Darby Canine Kidney Cells and in Human Endothelial Cells Induced to Synthesize Tissue Factor (*)

  1995cited by this paper
• Influence of IL-1 receptor blockade on the human response to endotoxemia.

  1995cited by this paper
• Interleukin 10 reduces mortality from severe peritonitis in mice

  1995cited by this paper
• Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury.

  1995cited by this paper
• Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia

  1995cited by this paper
• Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia.

  1995cited by this paper
• Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.

  1995cited by this paper
• Neutral endopeptidase modulation of septic shock

  1995cited by this paper
• In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons.

  1994cited by this paper
• A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon

  1994cited by this paper
• Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock.

  1994cited by this paper
• Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees

  1994cited by this paper
• Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees

  1994cited by this paper
• The inflammatory-coagulant axis in the host response to gram-negative sepsis: regulatory roles of proteins and inhibitors of tissue factor.

  1994cited by this paper
• Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate--the marmoset.

  1994cited by this paper
• The complement system in myocardial ischaemia/reperfusion injury.

  1994cited by this paper
• Retrospective description and experimental reconstitution of three different responses of the baboon to lethal E. coli.

  1994cited by this paper
• Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.

  1994cited by this paper
• Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans.

  1993cited by this paper
• Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium.

  1993cited by this paper
• Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.

  1993cited by this paper
• Endotoxin and Tumor Necrosis Factor-α-Induced Interleukin-8 Release in Humans

  1993cited by this paper
• Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans.

  1993cited by this paper
• Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.

  1993cited by this paper
• Elevated plasma interleukin-6 levels in patients with acute myocardial infarction.

  1993cited by this paper
• Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern

  1993cited by this paper
• Interleukin‐10 inhibits endotoxin‐induced tissue factor mRNA production by human monocytes

  1993cited by this paper
• Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration.

  1992cited by this paper
• Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

  1992cited by this paper
• Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans.

  1992cited by this paper
• Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.

  1992cited by this paper
• Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation

  1992cited by this paper
• The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.

  1992cited by this paper
• Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence.

  1992cited by this paper
• Interleukin-6 and its relation to the humoral immune response and clinical parameters in burned patients.

  1991cited by this paper
• Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.

  1991cited by this paper
• Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.

  1991cited by this paper
• Fibrinolytic response to tumor necrosis factor in healthy subjects

  1991cited by this paper
• Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa.

  1991cited by this paper
• C4b-binding protein exacerbates the host response to Escherichia coli.

  1991cited by this paper
• Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli.

  1991cited by this paper
• Sequential renal alterations in septic shock in the primate.

  1991cited by this paper
• DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage.

  1991cited by this paper
• Baboon model of Escherichia coli sepsis: description of its four stages and the role of tumor necrosis factor, tissue factors, and the protein C system in septic shock.

  1991cited by this paper
• Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).

  1990cited by this paper
• Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta

  1990cited by this paper
• Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

  1990cited by this paper
• In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets.

  1990cited by this paper
• Quantitative measurement of SC5b‐9 and C5b‐9(m) in infarcted areas of human myocardium

  1990cited by this paper
• Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.

  1990cited by this paper
• Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects.

  1989cited by this paper
• Comparative interactions of factor IX and factor IXa with human platelets.

  1989cited by this paper
• Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

  1989cited by this paper
• Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans.

  1989cited by this paper
• Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells.

  1989cited by this paper
• Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.

  1988cited by this paper
• Cytokine appearance in human endotoxemia and primate bacteremia.

  1988cited by this paper
• Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils.

  1988cited by this paper
• Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor

  1988cited by this paper
• The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.

  1988cited by this paper
• TUMOR NECROSIS FACTOR INCREASES THE PRODUCTION OF PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN ENDOTHELIAL CELLS IN VITRO AND IN RATS IN VIVO

  1988cited by this paper
• Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade.

  1988cited by this paper
• Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.

  1988cited by this paper
• The regulation of natural anticoagulant pathways

  1987cited by this paper
• Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

  1987cited by this paper
• C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma.

  1987influential reference
• Serum levels of interleukin-6 and acute phase responses.

  1987cited by this paper
• Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.

  1987cited by this paper
• Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.

  1987cited by this paper
• Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine.

  1987cited by this paper

• The efficiency of blood cell counts and inflammatory indices in prediction of need for acute kidney injury in patients with crush syndrome

  2025cites this paper
• Investigation of the protective effects of ethanolic extract of ferula orientalis on lung tissue in sepsis model rat

  2025cites this paper
• The role of thromboinflammation in acute kidney injury among patients with septic coagulopathy.

  2024cites this paper
• Effect of high-dose intravenous ascorbic acid on microcirculation and endothelial glycocalyx during sepsis and septic shock: a double-blind, randomized, placebo-controlled study

  2023cites this paper
• Vascular Proteome Responses Precede Organ Dysfunction in a Murine Model of Staphylococcus aureus Bacteremia

  2022cites this paper
• A rat model of septic shock using live Escherichia coli and response to Noradrenaline

  2022cites this paper
• Vascular proteome responses precede organ dysfunction in sepsis

  2021cites this paper
• Development of a minimal invasive and controllable murine model to study polymicrobial abdominal sepsis

  2021cites this paper
• Nonhuman primate species as models of human bacterial sepsis

  2019influential citation
• Crosstalk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation

  2019cites this paper
• Experimental Protocol for Cecal Ligation and Puncture Model of Polymicrobial Sepsis and Assessment of Vascular Functions in Mice.

  2018cites this paper
• Biomarkers in endotoxemia with a special interest in citrullinated histone H3

  2018cites this paper
• Comparison of two different models of sepsis induced by cecal ligation and puncture in rats.

  2018cites this paper
• Astilbin alleviates sepsis-induced acute lung injury by inhibiting the expression of macrophage inhibitory factor in rats

  2017cites this paper
• In vivo-generated thrombin and plasmin do not activate the complement system in baboons.

  2017cites this paper
• Astilbin alleviates sepsis-induced acute lung injury by inhibiting the expression of macrophage inhibitory factor in rats

  2017cites this paper
• Numerical Simulation of Thrombotic Occlusion in Tortuous Arterioles

  2017cites this paper
• Differential Paradigms in Animal Models of Sepsis

  2016cites this paper
• induced hemolytic uremic syndrome and thrombotic microangiopathy

  2016cites this paper
• Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention

  2015cites this paper
• Effects of sodium methyldithiocarbamate on selected parameters of innate immunity and clearance of bacteria in a mouse model of sepsis.

  2015cites this paper
• Complement, thrombotic microangiopathy and disseminated intravascular coagulation

  2014cites this paper
• Synthetic ligand-coated magnetic nanoparticles for microfluidic bacterial separation from blood.

  2014cites this paper
• Quiescent complement in nonhuman primates during E coli Shiga toxin-induced hemolytic uremic syndrome and thrombotic microangiopathy.

  2013cites this paper
• SEPSIS MODELS IN EXPERIMENTAL ANIMALS

  2013cites this paper
• Acute lung injury and fibrosis in a baboon model of Escherichia coli sepsis.

  2013cites this paper
• The Crosstalk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation

  2013cites this paper
• Plasma Bacterial and Mitochondrial DNA Distinguish Bacterial Sepsis From Sterile Systemic Inflammatory Response Syndrome and Quantify Inflammatory Tissue Injury in Nonhuman Primates

  2013cites this paper
• Plasmin‐dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia

  2013cites this paper
• Active site-inactivated factor VIIa inhibits nuclear factor kappa B activation in intestinal ischemia and reperfusion.

  2012cites this paper
• Pathophysiology, staging and therapy of severe sepsis in baboon models

  2012cites this paper
• Preclinical Sepsis Models

  2012cites this paper
• Thrombin-activatable fibrinolysis inhibitor is activated in vivo in a baboon model of Escherichia coli induced sepsis

  2012cites this paper
• Mitochondrial Debris as a Discriminator Between Inflammatory and Infectious Complications of Blast Injuries: The Enemy Within

  2012cites this paper
• Evidence for anti‐inflammatory effects of C5a on the innate IL‐17A/IL‐23 axis

  2012cites this paper
• Sepsis in tropical Australia : epidemiology, pathophysiology and adjunctive therapy

  2011cites this paper
• Tortuosity triggers platelet activation and thrombus formation in microvessels.

  2011cites this paper
• Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration

  2010cites this paper
• Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*

  2010cites this paper
• Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.

  2010cites this paper
• Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic

  2010cites this paper
• Polymicrobial sepsis and endotoxemia promote microvascular thrombosis via distinct mechanisms

  2010cites this paper
• Vascular and dendritic cell coagulation signaling in sepsis progression

  2009cites this paper
• Sistema de diagnóstico computadorizado para la clasificación del estrés oxidativo en un modelo de sepsis peritoneal en ratas

  2009cites this paper
• Phase 2 trial of eritoran tetrasodium ( E 5564 ) , a Toll-like receptor 4 antagonist , in patients with severe sepsis *

  2009cites this paper
• Fetal Inflammatory Response and Brain Injury in the Preterm Newborn

  2009cites this paper
• Immunological response to (1,4)-alpha-D-glucan in the lung and spleen of endotoxin-stimulated juvenile rats.

  2009cites this paper
• Scientific and clinical challenges in sepsis.

  2009cites this paper
• Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation

  2008cites this paper
• Differential Role of von Willebrand Factor and P-Selectin on Microvascular Thrombosis in Endotoxemia

  2008cites this paper
• Does activation of the blood coagulation cascade have a role in malaria pathogenesis?

  2008cites this paper
• EXPERIMENTAL MODELS OF SEPSIS AND THEIR CLINICAL RELEVANCE

  2008cites this paper
• Blood Coagulation, Inflammation, and Malaria

  2008cites this paper
• Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.

  2007cites this paper
• Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation.

  2007cites this paper
• Temporal dynamics of gene expression in the lung in a baboon model of E. coli sepsis

  2007influential citation
• Plasmodium falciparum‐ infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes

  2007cites this paper
• Chapter 13 – The Cross-Talk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation

  2007cites this paper
• Activated protein C

  2007cites this paper
• Sepsis and pathophysiology of anthrax in a nonhuman primate model.

  2006cites this paper
• Roles of protease-activated receptors in a mouse model of endotoxemia.

  2006cites this paper
• The endothelium in intensive care.

  2005cites this paper
• Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis*

  2005cites this paper
• Accidents hémorragiques au cours des traitements anticoagulants

  2005cites this paper
• Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis.

  2005cites this paper
• Is APC activation of endothelial cell PAR1 important in severe sepsis?: Yes

  2005cites this paper
• Pathogenesis of Malaria and Clinically Similar Conditions

  2004cites this paper
• In vitro evaluation of blood coagulation activation and microthrombus formation by a microchannel array flow analyzer.

  2004cites this paper
• Activated protein C in sepsis

  2004cites this paper
• Mechanisms underlying growth hormone effects in augmenting nitric oxide production and protein tyrosine nitration during endotoxin challenge.

  2004cites this paper
• Experimental models of sepsis and septic shock: an overview

  2004cites this paper
• Similar Conditions Pathogenesis of Malaria and Clinically

  2004cites this paper
• Chapter 150 – Pathophysiology of Neonatal Disseminated Intravascular Coagulation and Thrombosis

  2004cites this paper
• Comment on “Drotrecogin Alfa (activated) (recombinant human protein C, rhAPC) reduces host coagulopathy response in patients with severe sepsis”

  2003cites this paper
• The pathophysiology of falciparum malaria.

  2003cites this paper
• Reduced Neutrophil CD10 Expression in Nonhuman Primates and Humans After In Vivo Challenge with E. coli or Lipopolysaccharide

  2003cites this paper
• The blood coagulation system as a molecular machine.

  2003cites this paper
• Microvascular responses to sepsis: clinical significance.

  2002cites this paper
• Lipid metabolism and therapy

  2002cites this paper
• The association of disseminated intravascular coagulation with specific diseases

  2002cites this paper